Valuation Vext Science, Inc. Boerse Muenchen
Stocks
VV5
CA9255401064
Healthcare Facilities & Services
|
Market Closed -
Boerse Muenchen
06:43:35 25/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 0.1770 EUR | +0.57% |
|
+6.67% | +16.56% |
| 21/08 | Earnings Flash (VEXT.CN) Vext Science, Inc. Reports Q2 Revenue $12.1M | MT |
| 21/08 | Vext Science, Inc., Q2 2026 Earnings Call, Aug 20, 2026 |
Company Valuation: Vext Science, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 69.14 | 26.42 | 47.76 | 28.38 | 46.69 | 52.82 | - | - |
| Change | - | -61.79% | 80.79% | -40.58% | 64.53% | 13.15% | - | - |
| Enterprise Value (EV) 1 | 76.78 | 58.63 | 77.63 | 63.27 | 46.69 | 33.32 | 44.12 | 61.72 |
| Change | - | -23.63% | 32.4% | -18.51% | -26.21% | -28.62% | 32.41% | 39.89% |
| P/E | - | - | 7.07x | -1.43x | -2.66x | - | 20.7x | 7.07x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | 0x | 0.2x | - | - | 0x |
| Capitalization / Revenue | 1.86x | 0.75x | 1.37x | 0.79x | 0.91x | 0.98x | 0.77x | 0.69x |
| EV / Revenue | 2.06x | 1.66x | 2.23x | 1.76x | 0.91x | 0.62x | 0.64x | 0.8x |
| EV / EBITDA | 5.73x | 3.88x | 14x | 6.91x | - | 1.37x | 2.15x | 2.6x |
| EV / EBIT | - | - | -9.9x | -5.66x | - | 13.3x | 7.23x | 6.17x |
| EV / FCF | -10.8x | -20x | 46x | 34.7x | 5.73x | 7.95x | 2.73x | 2.76x |
| FCF Yield | -9.25% | -5.01% | 2.17% | 2.88% | 17.4% | 12.6% | 36.7% | 36.3% |
| Dividend per Share 3 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 3 | - | - | 0.041 | -0.115 | -0.0958 | - | 0.014 | 0.041 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 37.24 | 35.41 | 34.81 | 36 | 51.37 | 53.8 | 68.83 | 76.8 |
| EBITDA 1 | 13.39 | 15.12 | 5.528 | 9.153 | - | 24.35 | 20.5 | 23.7 |
| EBIT 1 | - | - | -7.843 | -11.18 | - | 2.5 | 6.1 | 10 |
| Net income 1 | - | - | - | - | -17.99 | -0.9 | 3.22 | 6.8 |
| Net Debt 1 | 7.635 | 32.22 | 29.88 | 34.89 | - | -19.5 | -8.7 | 8.9 |
| Reference price 3 | 0.6400 | 0.2400 | 0.2900 | 0.1650 | 0.2550 | 0.2900 | 0.2900 | 0.2900 |
| Nbr of stocks (in thousands) | 136,713 | 148,963 | 217,484 | 247,443 | 251,034 | 247,684 | - | - |
| Announcement Date | 20/4/22 | 22/3/23 | 10/5/24 | 31/3/25 | 29/4/26 | - | - | - |
1CAD in Million2USD in Million3CAD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 14.57x | 1.62x | 7.47x | - | 333M | |
| 2.12x | - | - | - | 175M | |
| 16.58x | - | - | - | 143M | |
| -1.26x | 0.7x | 3.03x | - | 95.51M | |
| Average | 8.00x | 1.16x | 5.25x | 186.43M | ||
| Weighted average by Cap. | 10.01x | 1.41x | 6.48x |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- VEXT Stock
- VV5 Stock
- Valuation Vext Science, Inc.
Select your edition
All financial news and data tailored to specific country editions
